[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335007-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335007-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-state-of-the-art-systematic-review-of-cancer-in-hidradenitis-suppurativa-systematic-review","A state-of-the-art systematic review of cancer in hidradenitis suppurativa - systematic review","","Hidradenitis suppurativa (HS) is a chronic inflammatory disease linked to increased malignancy risk. This systematic review investigates the prevalence of different cancers in patients with HS using PRISMA criteria and a data-driven keyword search. Among 443 initial publications, 25 studies met inclusion criteria. HS patients show significantly higher cancer risk, up to 50%, with severity-associated increases in multiple cancer types and malignant degeneration of lesions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-state-of-the-art-systematic-review-of-cancer-in-hidradenitis-suppurativa-systematic-review/335007/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-state-of-the-art-systematic-review-of-cancer-in-hidradenitis-suppurativa-systematic-review/335007.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of this systematic review on HS and cancer?","Question",{"text":63,"@type":64},"To investigate the prevalence of different malignancies in patients with hidradenitis suppurativa.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were studies selected for inclusion in the review?",{"text":68,"@type":64},"The review met PRISMA criteria and used a detailed, data-driven keyword search, considering various study designs while excluding reviews, summaries, letters to the editor, and non-human-population studies.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the review find about cancer risk in HS patients?",{"text":72,"@type":64},"HS patients have a significantly increased risk of cancer, up to 50%, and the risk of several specific cancers rises with HS severity; malignant degeneration can occur in severe cases, leading to cutaneous squamous cell carcinoma.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335007,1790239728,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","AnnAls of Medicine  \n2024, Vol. 56, no. 1, 2382372  \n[https://doi.org/10.1080/07853890.2024.2382372](https://doi.org/10.1080/07853890.2024.2382372)  \nReseaRch aRticle    \nA state-of-the-art systematic review of cancer in hidradenitis suppurativa  \nNessr abu Racheda,b* , Jonas Rütha,b*, thilo Gambichlerb,c,d, lennart Ockera,b and Falk G. Becharaa,b  \nainternational centre for Hidradenitis suppurativa/Acne inversa (icH), department of dermatology, Venereology and Allergology, Ruhr-University, Bochum, Germany; bskin cancer centre, department of dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany; cdepartment of dermatology and Phlebology, christian Hospital Unna, Unna, Germany; ddepartment of dermatology, dortmund Hospital gGmbH and faculty of Health, Witten/Herdecke University, dortmund, Germany  \nABSTRACT  \nPurpose: hidradenitis suppurativa (hs) is a chronic inflammatory disease associated with an increased risk of malignancy. the aim of this systematic review was to investigate the prevalence of different malignancies in hs.  \nMethods: this review meets the PRisMa criteria. a data-driven approach was used to conduct the research, which involved a detailed keyword search. the study considered meta-analyses, experimental studies, case-control studies, cross-sectional studies, cohort studies, and recently published cases, published in english or German. excluded were reviews, summaries, and letters to the editor, as well as studies, which are not based on the human population.  \nResults: Out of the initial 443 publications found, 25 met the inclusion criteria for this systematic review. Patients with hs have a significantly increased risk of cancer, up to 50%. additionally, the risk of oropharyngeal, central nervous system, colorectal, prostate, vulvar and non-melanocytic skin cancers increase with the severity of hs. the likelihood of comorbid lymphoma in patients with hs is significantly higher compared to healthy [controls. in](controls. in) severe cases of hs, malignant degeneration of lesions in the groin, perianal, perineal, and gluteal region can occur in up to 4.6% of cases. this leads to the development of cscc, which often have a complicated course, are more refractory to treatment and associated with a poorer outcome. the pathogenic mechanisms responsible for the malignant transformation of hs are currently unknown.  \nConclusions: Patients with hs have a higher risk of cancer compared to the general population. Untreated, long-standing hs lesions can lead to complicated malignant degeneration resulting in cutaneous squamous cell carcinoma. the mechanisms underlying this malignant degeneration are not fully understood. hs patients also have an increased risk of developing other cancers, including prostate, oral, pharyngeal and colorectal cancers of the central nervous system and lymphomas.  \nARTICLE HISTORY  \nReceived 12 March 2024 Revised 10 May 2024 accepted 12 May 2024  \nKEYWORDS  \nhidradenitis suppurativa; hs; malignant diseases; lymphoma; colorectal carcinoma; oropharyngeal  \ncarcinoma; cutaneoussquamous cell carcinoma; malignancy  \n1. Introduction  \nhidradenitis suppurativa (hs) is a chronically relapsing inflammatory skin disease that predominantly affects the axillary, submammary, genital, inguinal, and perianal regions. characteristically, a patient with hs develops inflammatory nodules, abscesses, sinuses, fistulas, scars, and contractures [1] . the global prevalence rate of hs is 0.4–1%[2,3] . in the caucasian population, the ratio of women to men is about 3:1 [4] . according to the hurley classification system, which is commonly used to categorise the clinical severity of hs, stage 1 is defined as non-scarring, transient abscesses without  \nsinus tracts, stage 2 is specified as the formation of a single sinus tract in recurrent abscesses, and stage 3 is designated as multiple abscesses, and fistulae with extensive scarring [5] . treatment options for hs include topical antisepti","cbCaihnrs03ZMfJy","https://ap.wps.com/l/cbCaihnrs03ZMfJy","pdf",1292935,21,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusions\n# 1. Introduction\n# Article history\n# Keywords","[{\"question\":\"What was the purpose of this systematic review on HS and cancer?\",\"answer\":\"To investigate the prevalence of different malignancies in patients with hidradenitis suppurativa.\"},{\"question\":\"How were studies selected for inclusion in the review?\",\"answer\":\"The review met PRISMA criteria and used a detailed, data-driven keyword search, considering various study designs while excluding reviews, summaries, letters to the editor, and non-human-population studies.\"},{\"question\":\"What did the review find about cancer risk in HS patients?\",\"answer\":\"HS patients have a significantly increased risk of cancer, up to 50%, and the risk of several specific cancers rises with HS severity; malignant degeneration can occur in severe cases, leading to cutaneous squamous cell carcinoma.\"}]","A state-of-the-art systematic review of cancer in hidradenitis suppurativa - systematic review | PDF",1790009203,53]